1033 related articles for article (PubMed ID: 1976464)
1. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
2. CD4 cells from patients with autoimmune thyroid disease secrete interferon gamma after stimulation by thyroid microsomal antigen; CD8 cells suppress this secretion.
Sakatsume Y; Matsubayashi S; Kasuga Y; Iitaka M; Iwatani Y; Volpé R
J Endocrinol Invest; 1990 Oct; 13(9):717-26. PubMed ID: 1981372
[TBL] [Abstract][Full Text] [Related]
3. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
4. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
[TBL] [Abstract][Full Text] [Related]
5. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
6. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
Ohashi H; Okugawa T; Itoh M
Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
[TBL] [Abstract][Full Text] [Related]
7. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
8. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
[TBL] [Abstract][Full Text] [Related]
9. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
10. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Miller N; Volpé R
Horm Metab Res; 1994 Sep; 26(9):419-23. PubMed ID: 7835825
[TBL] [Abstract][Full Text] [Related]
11. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
12. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.
MacLean DB; Miller KB; Brown R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056
[TBL] [Abstract][Full Text] [Related]
13. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
14. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
15. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M
Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
[TBL] [Abstract][Full Text] [Related]
16. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
17. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.
Murakami M; Miyashita K; Kakizaki S; Saito S; Yamada M; Iriuchijima T; Takeuchi T; Mori M
Eur J Endocrinol; 1995 Jul; 133(1):80-6. PubMed ID: 7627342
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]